Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Plantation › NPI 1063466589
Hospital

Columbia Hospital Corporation of South Broward

Columbia Hospital Corporation of South Broward was paid $9.83M by Medicaid between Jan 2018 and Dec 2024, across 153 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.

33Billing provider infoCOLUMBIA HOSPITAL CORPORATION OF SOUTH BROWARD
PLANTATION, FL 33324
33aNPI1063466589assigned 05/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.83M
24GClaims500,914
24DCodes billed153
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#53 of 163
Median peer was paid$4.77M
This provider vs. median2.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201828,338$258K
201974,809$553K
202047,772$462K
202171,738$1.47M
2022134,395$3.53M
2023101,664$2.30M
2024incomplete42,198$1.26M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 29% 43,529 39,182 $2.87M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 29,340 25,208 $1.35M
80053 Comprehensive metabolic panel 5.6% 14,281 11,615 $551K
70450 Computed tomography, head or brain; without contrast material 4.7% 5,413 4,352 $463K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.6% 5,872 5,495 $450K
74176 Computed tomography, abdomen and pelvis; without contrast material 4.4% 2,480 2,121 $435K
87070 3.9% 5,319 5,126 $383K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 2,111 1,862 $324K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.3% 6,613 5,319 $322K
80048 Basic metabolic panel (calcium, ionized) 3.0% 15,190 11,964 $297K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.4% 2,916 2,685 $241K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 667 597 $140K
141 more codes
96361 Intravenous infusion, hydration; each additional hour 1.1% 1,551 $112K
80047 1.1% 4,390 $106K
81025 1.0% 7,386 $101K
G0378 Hospital observation service, per hour 1.0% 7,671 $101K
72125 Computed tomography, cervical spine; without contrast material <1% 1,206 $79K
71045 Radiologic examination, chest; single view <1% 18,936 $76K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,173 $72K
80076 <1% 6,308 $72K
84702 <1% 2,338 $63K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,413 $61K
74022 <1% 675 $60K
71046 Radiologic examination, chest; 2 views <1% 1,917 $59K
87040 <1% 2,801 $57K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 530 $57K
73630 <1% 1,182 $52K
84484 <1% 12,690 $50K
74018 <1% 811 $49K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 460 $43K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 11,067 $40K
73130 <1% 725 $39K
87275 <1% 13,640 $35K
73564 <1% 929 $35K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,253 $34K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 6,100 $29K
93971 <1% 372 $29K
73030 <1% 684 $28K
76830 Ultrasound, transvaginal <1% 495 $26K
A9270 Non-covered item or service <1% 12,680 $25K
73110 <1% 359 $23K
72100 <1% 560 $21K
85027 <1% 36,844 $21K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 15,902 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 805 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 556 $18K
J7030 Infusion, normal saline solution , 1000 cc <1% 12,774 $16K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 539 $16K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,676 $16K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,839 $16K
86850 <1% 1,309 $14K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 931 $14K
73610 <1% 865 $13K
S0028 Injection, famotidine, 20 mg <1% 1,112 $10K
81001 <1% 7,482 $9K
81003 <1% 5,291 $9K
85610 <1% 9,185 $9K
85730 <1% 8,853 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,906 $8K
70486 <1% 109 $8K
93976 <1% 47 $8K
93970 <1% 68 $8K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 508 $8K
87276 <1% 13,636 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,956 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,614 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,481 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,688 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 4,751 $4K
72131 <1% 91 $4K
83690 <1% 10,204 $4K
84703 <1% 7,451 $4K
73080 <1% 62 $3K
76801 <1% 1,340 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,520 $3K
73502 <1% 135 $3K
83880 <1% 4,222 $3K
84443 Thyroid stimulating hormone (TSH) <1% 1,392 $2K
82040 <1% 969 $2K
84450 <1% 967 $2K
84460 <1% 968 $2K
84075 <1% 969 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,588 $2K
84155 <1% 966 $2K
82247 <1% 971 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,853 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 398 $2K
73140 <1% 15 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,558 $2K
71250 <1% 14 $2K
10060 <1% 93 $1K
J7120 Ringers lactate infusion, up to 1000 cc <1% 237 $1K
12001 <1% 30 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,513 $1K
86900 <1% 2,303 $1K
73590 <1% 19 $949.16
73562 <1% 15 $870.57
72040 <1% 12 $823.92
82550 <1% 1,262 $805.26
87807 <1% 1,884 $787.77
71101 <1% 13 $709.98
83605 <1% 2,774 $706.86
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 29 $685.93
82248 <1% 1,564 $656.50
85379 <1% 1,482 $558.57
86901 <1% 2,317 $548.29
J1815 Injection, insulin, per 5 units <1% 562 $547.80
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 444 $546.89
90714 <1% 331 $545.01
J3010 Injection, fentanyl citrate, 0.1 mg <1% 142 $542.61
83735 <1% 2,124 $541.21
J2060 Injection, lorazepam, 2 mg <1% 648 $520.50
72070 <1% 26 $467.54
12011 <1% 12 $462.75
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,594 $462.19
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,411 $429.49
73090 <1% 14 $421.44
J1170 Injection, hydromorphone, up to 4 mg <1% 905 $382.46
87186 <1% 40 $351.18
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 378 $347.15
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 510 $284.11
J7050 Infusion, normal saline solution, 250 cc <1% 2,325 $276.95
J3490 Unclassified drugs <1% 293 $172.68
97162 <1% 43 $153.72
80061 Lipid panel <1% 542 $138.30
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 255 $116.92
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,727 $105.36
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 583 $105.36
82150 <1% 141 $89.56
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 354 $60.97
J0360 Injection, hydralazine hcl, up to 20 mg <1% 366 $52.68
86140 <1% 700 $50.23
82553 <1% 218 $35.48
84100 <1% 184 $6.75
85651 <1% 471 $6.60
87081 <1% 17 $5.40
85007 <1% 422 $4.50
J2704 Injection, propofol, 10 mg 0% 152 $0.00
C1769 Guide wire 0% 48 $0.00
87205 0% 91 $0.00
96376 0% 318 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 70 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 204 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 59 $0.00
82077 0% 15 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 19 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 32 $0.00
82805 0% 53 $0.00
82010 0% 32 $0.00
36600 0% 37 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 15 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 14 $0.00
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUGHES, MATT (CFO)